|
Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998. |
|||||||||||||||||||||
Ultragenyx Pharmaceutical Inc. - Common Stock (NQ:RARE)Price and VolumeDetailed Quote
Top NewsMore News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
November 05, 2025
PerformanceMore NewsRead More
Earnings Scheduled For November 4, 2025 ↗
November 04, 2025
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 19, 2025
Assessing Ultragenyx Pharmaceutical: Insights From 8 Financial Analysts ↗
September 05, 2025
FDA Outlines Process To Speed Up Rare Disease Therapy Approvals ↗
September 04, 2025
10 Health Care Stocks Whale Activity In Today's Session ↗
September 02, 2025
Ultragenyx to Participate at Investor Conferences in September
August 29, 2025
Frequently Asked QuestionsIs Ultragenyx Pharmaceutical Inc. - Common Stock publicly traded?
Yes, Ultragenyx Pharmaceutical Inc. - Common Stock is publicly traded.
What exchange does Ultragenyx Pharmaceutical Inc. - Common Stock trade on?
Ultragenyx Pharmaceutical Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ultragenyx Pharmaceutical Inc. - Common Stock?
The ticker symbol for Ultragenyx Pharmaceutical Inc. - Common Stock is RARE on the Nasdaq Stock Market
What is the current price of Ultragenyx Pharmaceutical Inc. - Common Stock?
The current price of Ultragenyx Pharmaceutical Inc. - Common Stock is 33.10
When was Ultragenyx Pharmaceutical Inc. - Common Stock last traded?
The last trade of Ultragenyx Pharmaceutical Inc. - Common Stock was at 11/17/25 09:57 AM ET
What is the market capitalization of Ultragenyx Pharmaceutical Inc. - Common Stock?
The market capitalization of Ultragenyx Pharmaceutical Inc. - Common Stock is 2.34B
How many shares of Ultragenyx Pharmaceutical Inc. - Common Stock are outstanding?
Ultragenyx Pharmaceutical Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
|
||||||||||||||||||||
|
|||||||||||||||||||||